These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

895 related items for PubMed ID: 15870947

  • 1. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K, Takemura K, Kihara M, Naito S, Lee E, Shimizu E, Yamauchi A.
    Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
    [Abstract] [Full Text] [Related]

  • 2. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S, Ng CP, Bonavida B.
    Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
    Cho HJ, Kim JK, Kim KD, Yoon HK, Cho MY, Park YP, Jeon JH, Lee ES, Byun SS, Lim HM, Song EY, Lim JS, Yoon DY, Lee HG, Choe YK.
    Cancer Lett; 2006 Jun 08; 237(1):56-66. PubMed ID: 16009487
    [Abstract] [Full Text] [Related]

  • 5. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.
    Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810
    [Abstract] [Full Text] [Related]

  • 6. Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells.
    Hajji N, Wallenborg K, Vlachos P, Nyman U, Hermanson O, Joseph B.
    Oncogene; 2008 May 15; 27(22):3134-44. PubMed ID: 18071312
    [Abstract] [Full Text] [Related]

  • 7. Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells.
    Lin HI, Lee YJ, Chen BF, Tsai MC, Lu JL, Chou CJ, Jow GM.
    Cancer Lett; 2005 Dec 18; 230(2):248-59. PubMed ID: 16297711
    [Abstract] [Full Text] [Related]

  • 8. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ, Ng LT, Lin CC.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):96-106. PubMed ID: 16054126
    [Abstract] [Full Text] [Related]

  • 9. Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells.
    Khanna N, Jayaram HN, Singh N.
    Life Sci; 2004 May 28; 75(2):179-90. PubMed ID: 15120570
    [Abstract] [Full Text] [Related]

  • 10. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
    Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K.
    Apoptosis; 2006 Oct 28; 11(10):1813-23. PubMed ID: 16850165
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells.
    Ikuta K, Takemura K, Kihara M, Nishimura M, Ueda N, Naito S, Lee E, Shimizu E, Yamauchi A.
    Oncol Rep; 2005 Feb 28; 13(2):217-22. PubMed ID: 15643501
    [Abstract] [Full Text] [Related]

  • 12. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.
    Gynecol Oncol; 2002 Mar 28; 84(3):404-12. PubMed ID: 11855878
    [Abstract] [Full Text] [Related]

  • 13. Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells.
    Padilla LA, Leung BS, Carson LF.
    Gynecol Oncol; 2002 Apr 28; 85(1):59-66. PubMed ID: 11925121
    [Abstract] [Full Text] [Related]

  • 14. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL.
    Rashmi R, Kumar S, Karunagaran D.
    Carcinogenesis; 2005 Apr 28; 26(4):713-23. PubMed ID: 15661804
    [Abstract] [Full Text] [Related]

  • 15. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
    Checinska A, Hoogeland BS, Rodriguez JA, Giaccone G, Kruyt FA.
    Exp Cell Res; 2007 Apr 01; 313(6):1215-24. PubMed ID: 17291493
    [Abstract] [Full Text] [Related]

  • 16. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK, Schadendorf D, Röckmann H.
    Melanoma Res; 2006 Dec 01; 16(6):527-35. PubMed ID: 17119454
    [Abstract] [Full Text] [Related]

  • 17. Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide.
    Brumatti G, Yon M, Castro FA, Bueno-da-Silva AE, Jacysyn JF, Brunner T, Amarante-Mendes GP.
    Exp Cell Res; 2008 Feb 01; 314(3):554-63. PubMed ID: 18078929
    [Abstract] [Full Text] [Related]

  • 18. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
    Raffo AJ, Kim AL, Fine RL.
    Oncogene; 2000 Dec 14; 19(54):6216-28. PubMed ID: 11175336
    [Abstract] [Full Text] [Related]

  • 19. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED, Kutuk O, Tezil T, Bodur C, Telci D, Basaga H.
    Breast Cancer Res Treat; 2010 Jan 14; 119(2):271-81. PubMed ID: 19238538
    [Abstract] [Full Text] [Related]

  • 20. Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells.
    Kuhar M, Sen S, Singh N.
    Anticancer Res; 2006 Jan 14; 26(2A):1297-303. PubMed ID: 16619537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.